U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C20H25FN4O
Molecular Weight 356.4371
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NIAPRAZINE

SMILES

CC(CCN1CCN(CC1)C2=CC=C(F)C=C2)NC(=O)C3=CC=CN=C3

InChI

InChIKey=RSKQGBFMNPDPLR-UHFFFAOYSA-N
InChI=1S/C20H25FN4O/c1-16(23-20(26)17-3-2-9-22-15-17)8-10-24-11-13-25(14-12-24)19-6-4-18(21)5-7-19/h2-7,9,15-16H,8,10-14H2,1H3,(H,23,26)

HIDE SMILES / InChI

Molecular Formula C20H25FN4O
Molecular Weight 356.4371
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Niaprazine is a potent and selective antagonist of 5-HT2A and alpha-1 adrenergic receptors. It was used for the treatment of sleep disturbances in children and was investigated for the treatment of sleep disorders in patients with attention-deficit hyperactivity disorder and autistic disorder.

Approval Year

PubMed

PubMed

TitleDatePubMed
Insomnia in children: when are hypnotics indicated?
2002
Drug use in children: cohort study in three European countries.
2008 Nov 24
Niaprazine may improve some symptoms of attention-deficit hyperactivity disorder.
2010 Apr
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:01:49 GMT 2025
Edited
by admin
on Mon Mar 31 19:01:49 GMT 2025
Record UNII
R2H3YN6E3L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NOPRON
Preferred Name English
NIAPRAZINE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
N-(3-(4-(4-FLUOROPHENYL)-1-PIPERAZINYL)-1-METHYLPROPYL)-3-PYRIDINECARBOXAMIDE
Systematic Name English
Niaprazine [WHO-DD]
Common Name English
1709 CERM
Code English
NIAPRAZINE [MI]
Common Name English
1709CERM
Code English
1709-CERM
Code English
NIAPRAZINE [MART.]
Common Name English
J10.716F
Code English
niaprazine [INN]
Common Name English
NICOTINAMIDE, N-(3-(4-(P-FLUOROPHENYL)-1-PIPERAZINYL)-1-METHYLPROPYL)-
Common Name English
3-PYRIDINECARBOXAMIDE, N-(3-(4-(4-FLUOROPHENYL)-1-PIPERAZINYL)-1-METHYLPROPYL)-
Systematic Name English
Classification Tree Code System Code
WHO-VATC QN05CM16
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
WHO-ATC N05CM16
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
NCI_THESAURUS C29756
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
Code System Code Type Description
MERCK INDEX
m7847
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY Merck Index
MESH
C021062
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
ChEMBL
CHEMBL2105141
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
INN
2817
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
DRUG BANK
DB13687
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
DRUG CENTRAL
1908
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
PUBCHEM
71919
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
ECHA (EC/EINECS)
248-431-5
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
EPA CompTox
DTXSID10865369
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
CAS
27367-90-4
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
WIKIPEDIA
Niaprazine
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
RXCUI
31722
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY RxNorm
EVMPD
SUB09218MIG
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
NCI_THESAURUS
C76943
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
SMS_ID
100000084183
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
FDA UNII
R2H3YN6E3L
Created by admin on Mon Mar 31 19:01:49 GMT 2025 , Edited by admin on Mon Mar 31 19:01:49 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
ENANTIOMER -> RACEMATE
TARGET -> INHIBITOR
Ki
TARGET -> INHIBITOR
Ki
ENANTIOMER -> RACEMATE
Related Record Type Details
METABOLITE ACTIVE -> PARENT
Identified in the urine specimens from rat (5 mg/kg, po), dog (5 mg/kg, po) and man (1 mg/kg, po).
IN-VIVO
URINE
Related Record Type Details
ACTIVE MOIETY